TOP 5 HEALTHCARE FOREIGN INVESTMENTS FROM 13 TO 18 APRIL 2020
Posted On : Apr 18, 2020/Biotechnology
The top five foreign investments news between 13thto 18th April 2020: The leading private equity and asset management firm Blackstone announced a strategic collaboration with Alnylam Pharmaceuticals to support the advancement of innovative RNA interference (RNAi) medicines by the Alnylam. Blackstone support Alnylam with approximately $2 billion, In response to Covid-19 pandemic ZF North America a subsidiary of ZF Friedrichshafen AG has announced its partnership with Michigan-based Detroit Sewn to the fight against coronavirus. As per agreement 100,000 face masks is expected to be delivered to Detroit Sewn by the end of April 2020, Coronavirus (COVID-19) epidemic is spreading to whole world. In response to this the World Bank has announced an emergency fund of $20 million for Papua New Guinea (PNG) to fight against COVID-19, GlaxoSmithKline is a leading global pharmaceutical company announced that it has signed a letter of intent with Sanofi to develop an adjuvanted vaccine for COVID-19. Both companies will use innovative technology to help address the ongoing pandemic, and The United States Department of Health and Human Services (HHS) has announced five new contracts rated under the Defense Production Act (DPA), for ventilator production. HHS has signed contracts with Medtronic, General Electric, Hill-Rom, ResMed, and Vyaire, as well as two other contracts for ventilator production, to Hamilton and Zoll.